Raffaele Giusti: First global survey on medical cannabis in oncology
Raffaele Giusti, Medical director at Azienda Ospedaliera Sant’Andrea, shared a post on X:
“First global survey on medical cannabis in oncology highlights limited awareness of guidelines, regional differences, and legislative barriers.
Calls for clearer regulations and education to improve cancer care.”
Authors: Trapani Dario, J Nidhamalddin Sarac, Gandini Sarad, Filetti Marcoe, C Altuna Saraf, Carnevale Schianca Ambraa, Petrillo Angelicag, M Murthy Shilpah, Girardi Fabioi, B Bezuidenhout Jacquesj, El Bairi Khalidk, Lombardi Pasqualee, Z Khan Shahm, G Lengyel Csongorn, Seeber Andreaso, Hussain Sadaqatp, U Seid Fahmiq, Elfaham Essamr, O Odhiambo Andrews, Coskun Yakupt, S Habeeb Bakeru, R Chowdhury Armanv, Genazzani Armandow, Daniele Gennaroe, Porzio Giampieroy, Curigliano Giuseppe and Giusti Raffaele
Dario Trapani, Medical Oncology Resident and Research Fellow at IEO European Institute of Oncology, also reshared the post:
“Come and take a look to the TASMAN study on the use of medical cannabis in cancer care.”
Dario Trapani is a medical oncologist at the European Institute of Oncology (IEO) and a researcher in the Department of Oncology and Hemato-oncology at the University of Milan. He previously served as a Postdoctoral Researcher at the Dana-Farber Cancer Institute and is focused on population health research.
More posts featuring Raffaele Giusti and Dario Trapani.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023